skip to content
  1. Home
  2. >
  3. Questions
  4. >
  5. CGX: Please comment on the year-end numbers. [Cineplex Inc.]
You can view 2 more answers this month. Sign up for a free trial for unlimited access.

Investment Q&A

Not investment advice or solicitation to buy/sell securities. Do your own due diligence and/or consult an advisor.

Q: Please comment on the year-end numbers. The company seems to be moving in the right direction. Are there any comparable U.S. or Canadian public companies that can help an investor determine if the stock is undervalued relative to its peers?
Asked by Murray on June 13, 2025
5i Research Answer:

EPS of $0.27 beat estimates of $0.242 and sales of $96.01M beat estimates of $89.02M. Sales grew 14.8% for the quarter, and it achieved organic growth of 16.1%. Adjusted EBITDA expanded 19% and its repurchased $2.3M in shares. For the full-year it saw organic growth of 12.3%, and sales growth of 12%. These were strong Q4 numbers, which led to a big pop in the share price. It continues to trade at a decent valuation of 7.9X forward earnings, and pays a dividend yield of 3.0%. Analyst estimates rose sharply. 

A few comparables for RAY.A, include: WILD, CGX, CCA.

RAY.A does trade at a discounted valuation to its peers, and it also has some of the strongest EBIT and net profit margins. We think it looks interesting here if it can continue its recent growth momentum.

Let us help YOU reach your financial goals today!

Start your FREE trial today and enjoy all the benefits of a 5i Membership including:

  • Access to a team of experts ready to answer your investments question 
  • Instant access to over 100,000 archived questions
  • A community of like-minded investors
  • Peace of mind knowing that 5i Research has only YOUR best interests in mind